Immediate Impact
3 from Science/Nature 69 standout
Citing Papers
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of John Hanna being referenced
A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients
2020
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| John Hanna | 207 | 54 | 97 | 136 | 5 | 256 | |
| Juan Garcia‐Talavera | 170 | 100 | 88 | 91 | 9 | 290 | |
| Václav Šeda | 169 | 28 | 140 | 117 | 6 | 327 | |
| F Davi | 116 | 48 | 91 | 112 | 8 | 254 | |
| Rosella Famà | 209 | 53 | 92 | 170 | 9 | 277 | |
| E Moreau | 241 | 32 | 142 | 218 | 7 | 310 | |
| D. Janson | 254 | 74 | 129 | 174 | 9 | 327 | |
| Adam Albitar | 230 | 51 | 101 | 185 | 8 | 269 | |
| Binsah George | 250 | 99 | 84 | 187 | 8 | 284 | |
| Chiara Lobetti Bodoni | 101 | 25 | 45 | 108 | 8 | 184 | |
| Andy Boral | 174 | 68 | 61 | 147 | 4 | 275 |
All Works
Login with ORCID to disown or claim papers
Loading papers...